Authors:
Kupferwasser, LI
Hafner, G
Mohr-Kahaly, S
Erbel, R
Meyer, J
Darius, H
Citation: Li. Kupferwasser et al., The presence of infection-related antiphospholipid antibodies in infectiveendocarditis determines a major risk factor for embolic events, J AM COL C, 33(5), 1999, pp. 1365-1371
Authors:
Ries, MW
Rupprecht, HJ
Dudsjak, H
Hafner, G
Meyer, J
Citation: Mw. Ries et al., Release of troponin T following PTCA in patients with unstable and stable angina pectoris, Z KARDIOL, 88(11), 1999, pp. 914-921
Authors:
Humpl, T
Bruhl, K
Brzezinska, R
Hafner, G
Coerdt, W
Shearer, MJ
Citation: T. Humpl et al., Fatal late vitamin K-deficiency bleeding after oral vitamin K prophylaxis secondary to unrecognized bile duct paucity, J PED GASTR, 29(5), 1999, pp. 594-597
Authors:
Greiner, K
Hafner, G
Prellwitz, W
Pfeiffer, N
Citation: K. Greiner et al., Hereditary deficiencies in the protein C pathway in central retinal arteryocclusion and branch retinal artery occlusion, KLIN MONATS, 215(1), 1999, pp. 33-36
Authors:
Zacharowski, K
Otto, M
Hafner, G
Marsh, HC
Thiemermann, C
Citation: K. Zacharowski et al., Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x, BR J PHARM, 128(5), 1999, pp. 945-952
Authors:
Zacharowski, K
Olbrich, A
Otto, M
Hafner, G
Thiemermann, C
Citation: K. Zacharowski et al., Effects of the prostanoid EP3-receptor agonists M & B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat, BR J PHARM, 126(4), 1999, pp. 849-858